Sign Up to like & get
recommendations!
1
Published in 2023 at "Nuclear Medicine Communications"
DOI: 10.1097/mnm.0000000000001658
Abstract: Purpose For prostate-specific membrane antigen-directed radioligand therapy (PSMA-RLT), [177Lu]Lu-PSMA-617 and [177Lu]Lu-PSMA-I&T are the currently preferred compounds. Recent preclinical studies suggested ~30x higher kidney absorbed dose for [177Lu]Lu-PSMA-I&T compared to [177Lu]Lu-PSMA-617, which may lead to an…
read more here.
Keywords:
psma 617;
617 177lu;
177lu psma;
kidney absorbed ... See more keywords